Active	Status	Sponsor type	Region	Phase	Filter
12 Active 98 Inactive 110 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jude, Edward
NCT06695325: Convenient Home Access for Routine Monitoring in Diabetes (Charm-D Study)	Not yet recruiting	N/A	300	Europe	HbA1c test	Tameside General Hospital, Roche Diagnostic Ltd.	Diabetes Mellitus	12/25	12/25
Harris, Margaret
ASCERTAIN, NCT05834673: VICTORION- Implementation Study (v-)	Terminated	N/A	6	RoW	SMS messages, Monthly Text Messages, Telephone-based support calls, Nurse Support Calls, GP Education	Monash University, Novartis Pharmaceuticals	Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Heart Disease (CHD), Cerebrovascular Disease, Peripheral Arterial Disease (PAD)	12/24	12/24
Person, Contact
NCT03412643: Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling	Recruiting	2	64	US	Doxorubicin, Cyclophosphamide, Weekly Paclitaxel, Trastuzumab, Pertuzumab, Celcuity CELx HSF	NSABP Foundation Inc, Celcuity, LLC, Genentech, Inc.	HER2-negative Breast Cancer	10/23	10/23
Mihailescu, Andrei
LBF8-Open, NCT04059640: PMCF Study of LiquiBand FIX8® OHMF Device	Recruiting	N/A	107	Europe	LiquiBand FIX8 Open Hernia Mesh Fixation Device	Advanced Medical Solutions Ltd., Imarc Research, Inc.	Inguinal Hernia	05/25	08/25